Organon & Co.
OGN
$6.45
$0.111.66%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.51B | 1.60B | 1.59B | 1.51B | 1.59B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.51B | 1.60B | 1.59B | 1.51B | 1.59B |
| Cost of Revenue | 741.00M | 733.00M | 710.00M | 663.00M | 696.00M |
| Gross Profit | 766.00M | 869.00M | 884.00M | 850.00M | 896.00M |
| SG&A Expenses | 431.00M | 415.00M | 453.00M | 420.00M | 459.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.26B | 1.23B | 1.26B | 1.18B | 1.29B |
| Operating Income | 244.00M | 370.00M | 336.00M | 334.00M | 307.00M |
| Income Before Tax | -148.00M | 243.00M | 229.00M | 101.00M | 129.00M |
| Income Tax Expenses | 57.00M | 83.00M | 84.00M | 14.00M | 20.00M |
| Earnings from Continuing Operations | -205.00M | 160.00M | 145.00M | 87.00M | 109.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -205.00M | 160.00M | 145.00M | 87.00M | 109.00M |
| EBIT | 244.00M | 370.00M | 336.00M | 334.00M | 307.00M |
| EBITDA | 340.00M | 462.00M | 425.00M | 418.00M | 384.00M |
| EPS Basic | -0.79 | 0.62 | 0.56 | 0.34 | 0.42 |
| Normalized Basic EPS | 0.25 | 0.61 | 0.47 | 0.52 | 0.36 |
| EPS Diluted | -0.79 | 0.61 | 0.56 | 0.33 | 0.41 |
| Normalized Diluted EPS | 0.25 | 0.61 | 0.47 | 0.51 | 0.36 |
| Average Basic Shares Outstanding | 260.17M | 259.98M | 259.94M | 257.86M | 257.69M |
| Average Diluted Shares Outstanding | 260.17M | 260.65M | 260.16M | 261.00M | 259.88M |
| Dividend Per Share | 0.02 | 0.02 | 0.02 | 0.28 | 0.28 |
| Payout Ratio | -1.95% | 1.88% | 6.90% | 81.61% | 67.89% |